Interestingly, our data suggested that the decrease in PTG CaSR expression, which is important in the development of SHPT, was caused by the early decrease in PTG Gcm2 expression, followed by the effect of 1,25(OH)2D reduction, PTG VDR reduction, hypocalcemia and hyperphosphatemia. Here, GCM2 is linked to hyperphosphatemia.